Consumption and market share of cholesterol-lowering drugs in high-risk patients before and after the release of the 2013 ACC/AHA cholesterol guidelines: a retrospective observational study
Objective We examined the use of cholesterol-lowering drugs in Taiwan in high-risk patients before and after the release of the 2013 American College of Cardiology and the American Heart Association (ACC/AHA) cholesterol guidelines.Design Retrospective observational study.Setting Kaohsiung Chang Gun...
Saved in:
| Main Authors: | Tzu-Tsen Kuo, Yaw-Bin Huang, Ching-Jung Hsieh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/11/e036769.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines
by: Christopher N Floyd
Published: (2020-02-01) -
Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA
by: Gowsini Joseph, et al.
Published: (2024-12-01) -
Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01) -
Early-stage hypertension defined by the 2017 ACC/AHA blood pressure guideline carries excessive cardiovascular risk in axial spondyloarthritis patients
by: Lin-Hong Shi, et al.
Published: (2024-11-01) -
Impact of the 2017 ACC/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10 799 individuals
by: Ahmed Alaskar, et al.
Published: (2020-12-01)